Memorandum from NZSG

Posted Thursday April 6, 2023

The NZSG Working Group for IBD Medication after discussion with NZSG members, Pharmac and pharmaceutical company representatives have written an e-guidance document on ustenkinumab treatment and ongoing maintenance doses. Please find this on the NZSG website


Related Articles

Supply Issue Notice from Pharmac

Thursday February 15, 2024

We've received news about long-term supply issue affecting the Dipentum brand of olsalazine (250 mg capsules and 500 mg ...


Read more »

NZCCRTGE - Conjoint Committee News

Monday February 12, 2024

The NZCCRTGE has made a few changes we'd like to let you know about


Read more »

NZLTU Policy and Protocols Presented at ASM 2023

Wednesday December 13, 2023

Professor Ed Gane and Dr Hannah Giles presented several new referral policies for the NZLTU we would like to share with ...

News Resources

Read more »